Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ketorolac

A non-steroidal anti-inflammatory drug with strong pain-relieving action, patented in 1976 and approved in 1989. It is used for a few days in moderate to severe acute pain, also intravenously or intramuscularly. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?Besides tablets and injections it comes as eye drops, approved in the United States in 1992 and used for ocular itching and pain from eye surgery, and since 2010 even as a nasal spray.

KetorolacGo to the active ingredient →
KetorolacActive ingredientKetorolacCat. No. P-K008-001CAS 74103-06-3
Ketorolac-d5Isotopically labelledKetorolac-d5Cat. No. P-K008-014CAS 1215767-66-0

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.